Literature DB >> 15620267

Structural activity relationship studies of zebra mussel antifouling and antimicrobial agents from verongid sponges.

Jeffrey A Diers1, Hari Kishore Pennaka, Jiangnan Peng, John J Bowling, Stephen O Duke, Mark T Hamann.   

Abstract

Several dibromotyramine derivatives including moloka'iamine were selected as potential zebra mussel (Dreissena polymorpha) antifoulants due to the noteworthy absence of fouling observed on sponges of the order Verongida. Sponges of the order Verongida consistently produce these types of bromotyrosine-derived secondary metabolites. Previously reported antifouling data for the barnacle Balanus amphitrite(EC50 = 12.2 microM) support the results reported here that the compound moloka'iamine may be a potential zebra mussel antifoulant compound (EC50 = 10.4 microM). The absence of phytotoxic activity of the compound moloka'iamine toward Lemna pausicostata and, most importantly, the compound's significant selectivity against macrofouling organisms such as zebra mussels suggest the potential utility of this compound as a naturally derived antifoulant lead.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15620267      PMCID: PMC4928192          DOI: 10.1021/np040097t

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  6 in total

1.  Ceratinamine: An Unprecedented Antifouling Cyanoformamide from the Marine Sponge Pseudoceratina purpurea.

Authors:  Sachiko Tsukamoto; Haruko Kato; Hiroshi Hirota; Nobuhiro Fusetani
Journal:  J Org Chem       Date:  1996-05-03       Impact factor: 4.354

2.  Dose-response relationships between herbicides with different modes of action and growth of Lemna paucicostata: an improved ecotoxicological method.

Authors:  Albrecht Michel; Robert D Johnson; Stephen O Duke; Brian E Scheffler
Journal:  Environ Toxicol Chem       Date:  2004-04       Impact factor: 3.742

3.  7-Hydroxyceratinamine, a new cyanoformamide-containing metabolite from a sponge, Aplysinella sp.

Authors:  X Fu; F J Schmitz
Journal:  J Nat Prod       Date:  1999-07       Impact factor: 4.050

4.  Mololipids, a new series of anti-HIV bromotyramine-derived compounds from a sponge of the order verongida.

Authors:  S A Ross; J D Weete; R F Schinazi; S S Wirtz; P Tharnish; P J Scheuer; M T Hamann
Journal:  J Nat Prod       Date:  2000-04       Impact factor: 4.050

5.  Cytotoxic, antifouling bromotyramines: a synthetic study on simple marine natural products and Their analogues.

Authors:  Ryan C Schoenfeld; Susan Conova; Daniel Rittschof; Bruce Ganem
Journal:  Bioorg Med Chem Lett       Date:  2002-03-11       Impact factor: 2.823

6.  A new dibromotyrosine-derived metabolite from the sponge psammaplysilla purpurea1

Authors: 
Journal:  J Nat Prod       Date:  1998-11       Impact factor: 4.050

  6 in total
  8 in total

Review 1.  The marine bromotyrosine derivatives.

Authors:  Jiangnan Peng; Jing Li; Mark T Hamann
Journal:  Alkaloids Chem Biol       Date:  2005

Review 2.  Principles of biofouling protection in marine sponges: a model for the design of novel biomimetic and bio-inspired coatings in the marine environment?

Authors:  Werner E G Müller; Xiaohong Wang; Peter Proksch; Carole C Perry; Ronald Osinga; Johan Gardères; Heinz C Schröder
Journal:  Mar Biotechnol (NY)       Date:  2013-03-26       Impact factor: 3.619

3.  Modification at the C9 position of the marine natural product isoaaptamine and the impact on HIV-1, mycobacterial, and tumor cell activity.

Authors:  Waseem Gul; Nicholas L Hammond; Muhammad Yousaf; John J Bowling; Raymond F Schinazi; Susan S Wirtz; Garcia de Castro Andrews; Carmen Cuevas; Mark T Hamann
Journal:  Bioorg Med Chem       Date:  2006-10-11       Impact factor: 3.641

4.  Zebra mussel antifouling activity of the marine natural product aaptamine and analogs.

Authors:  Jeffrey A Diers; John J Bowling; Stephen O Duke; Subagus Wahyuono; Michelle Kelly; Mark T Hamann
Journal:  Mar Biotechnol (NY)       Date:  2006-05-26       Impact factor: 3.619

5.  Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma.

Authors:  Mikell Paige; George Kosturko; Güllay Bulut; Matthew Miessau; Said Rahim; Jeffrey A Toretsky; Milton L Brown; Aykut Üren
Journal:  Bioorg Med Chem       Date:  2013-11-14       Impact factor: 3.641

6.  Synthesis and Antiproliferative Activity of Marine Bromotyrosine Purpurealidin I and Its Derivatives.

Authors:  Chinmay Bhat; Polina Ilina; Irene Tilli; Manuela Voráčová; Tanja Bruun; Victoria Barba; Nives Hribernik; Katja-Emilia Lillsunde; Eero Mäki-Lohiluoma; Tobias Rüffer; Heinrich Lang; Jari Yli-Kauhaluoma; Paula Kiuru; Päivi Tammela
Journal:  Mar Drugs       Date:  2018-12-03       Impact factor: 5.118

7.  Biological importance of marine algae.

Authors:  Ali A El Gamal
Journal:  Saudi Pharm J       Date:  2010-01       Impact factor: 4.330

8.  Bioactive Bromotyrosine Derivatives from the Pacific Marine Sponge Suberea clavata (Pulitzer-Finali, 1982).

Authors:  Céline Moriou; Damien Lacroix; Sylvain Petek; Amr El-Demerdash; Rozenn Trepos; Tinihauarii Mareva Leu; Cristina Florean; Marc Diederich; Claire Hellio; Cécile Debitus; Ali Al-Mourabit
Journal:  Mar Drugs       Date:  2021-03-06       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.